Satoshi Oeda

Dr. Satoshi Oeda

Saga University

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2020 in Diagnostics
Verified
Journal Article
Open access
PDF file
SOSatoshi Oeda
Satoshi Oeda
KTKenichi Tanaka
Kenichi Tanaka
AOAyaka Oshima
Ayaka Oshima
YMYasue Matsumoto
Yasue Matsumoto
ESEisaburo Sueoka
Eisaburo Sueoka
Atsushi  NakajimaAtsushi Nakajima
Atsushi Nakajima
Evaluating liver steatosis and fibrosis is important for patients with non-alcoholic fatty liver disease. Although liver biopsy and pathological assessment is the gold standard for these conditions, this technique has several disadvantages. The evaluation of steatosis and fibrosis using ultrasound B-mode imaging is qualitative and subjective. The liver stiffness measurement (LSM) and controlled attenuation parameter (CAP) determined using FibroScan are the evidence-based non-invasive measures of liver fibrosis and steatosis, respectively. The LSM and CAP measurements are carried out simultaneously, and the median values of more than ten valid measurements are used to quantify liver fibrosis and steatosis. Here, we demonstrate that the reliability of the LSM depends on the interquartile range to median ratio (IQR/Med), but CAP values do not depend on IQR/Med. In addition, the LSM is affected by inflammation, congestion, and cholestasis in addition to fibrosis, while CAP values are affected by the body mass index in addition to steatosis. We also show that the M probe provides higher LSM values but lower CAP values than the XL probe in the same population. However, there was no statistically significant difference between the diagnostic accuracies of the two probes. These findings are important to understand the reliability of FibroScan measurements and the factors influencing measurement values for all patients.

18 February 2012 in Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
TOTaiga Otsuka
Taiga Otsuka
SKSeiji Kawazoe
Seiji Kawazoe
SNShunya Nakashita
Shunya Nakashita
SKSaori Kamachi
Saori Kamachi
SOSatoshi Oeda
Satoshi Oeda
TNTakahiro Noda
Takahiro Noda

28 September 2010 in Hepatology Research
Verified
Journal Article
Closed access
PDF file
Hirokazu TakahashiHirokazu Takahashi
Hirokazu Takahashi
TMToshihiko Mizuta
Toshihiko Mizuta
SKSeiji Kawazoe
Seiji Kawazoe
YEYuichiro Eguchi
Yuichiro Eguchi
YKYasunori Kawaguchi
Yasunori Kawaguchi
KFKazuma Fujimoto
Kazuma Fujimoto

11 October 2015 in Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
KTKatsutoshi Tokushige
Katsutoshi Tokushige
HHHideyuki Hyogo
Hideyuki Hyogo
TNTomoaki Nakajima
Tomoaki Nakajima
MOMasafumi Ono
Masafumi Ono
TKTakumi Kawaguchi
Takumi Kawaguchi
EHEtsuko Hashimoto
Etsuko Hashimoto

26 April 2020 in Hepatology Research
Verified
Journal Article
Closed access
PDF file
SOSatoshi Oeda
Satoshi Oeda
HTHirokazu Takahashi
Hirokazu Takahashi
KIKento Imajo
Kento Imajo
YSYuya Seko
Yuya Seko
TKTakashi Kobayashi
Takashi Kobayashi
ANAtsushi Nakajima
Atsushi Nakajima

16 January 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
KMKenichiro Murayama
Kenichiro Murayama
MOMichiaki Okada
Michiaki Okada
KTKenichi Tanaka
Kenichi Tanaka
CIChika Inadomi
Chika Inadomi
WYWataru Yoshioka
Wataru Yoshioka
Atsushi  NakajimaAtsushi Nakajima
Atsushi Nakajima
Access to imaging is limited for diagnosing nonalcoholic fatty liver disease (NAFLD) in general populations. This study evaluated the diagnostic performance of noninvasive and nonimaging indexes to predict NAFLD in the general Japanese population. Health checkup examinees without hepatitis virus infection or habitual alcohol drinking were included. Fatty liver was diagnosed by ultrasonography. The hepatic steatosis index (HSI), Zhejiang University (ZJU) index, and fatty liver index (FLI) were determined, and risk of advanced liver fibrosis was evaluated by the fibrosis-4 index. NAFLD was diagnosed in 1935 (28.0%) of the 6927 subjects. The area under the receiver operating characteristic (AUROC) curve of the HSI, ZJU index, and FLI was 0.874, 0.886, and 0.884, respectively. The AUROC of the ZJU index (p < 0.001) and FLI (p = 0.002) was significantly greater than that for the HSI. In subjects with a high risk of advanced fibrosis, the sensitivity of the HSI, ZJU index, and FLI were 88.8%, 94.4%, and 83.3% with a low cut-off value and the specificity was 98.5%, 100%, and 100% with a high cut-off value. In conclusion, all indexes were useful to diagnose NAFLD in the general Japanese population and in subjects with potentially advanced liver fibrosis.